Skip to main content
. 2019 Feb 11;37(10):780–789. doi: 10.1200/JCO.18.00884

FIG 2.

FIG 2.

Outcomes for all patients with hypodiploid B-lymphoblastic leukemia (B-ALL). (A) All patients with hypodiploid B-ALL. (B) National Cancer Institute (NCI) standard-risk patients with hypodiploid B-ALL. (C) NCI high-risk patients with hypodiploid B-ALL. EFS, event-free survival; OS, overall survival.